72. Remdesivir vs Standard Care in Patients with Moderate covid-19
Sign Up to like & getrecommendations! Published in 2020 at "Open Forum Infectious Diseases"
DOI: 10.1093/ofid/ofaa439.382
Abstract: Background: Remdesivir (RDV) shortens time to recovery time in patients with severe COVID-19 Its effect in patients with moderate COVID-19 remains unclear Methods: We conducted an open-label, phase 3 trial (NCT04252664) involving hospitalized patients with… read more here.
Keywords: 10d rdv; rdv; moderate covid; patients moderate ... See more keywords